Zejing Wang, MD/PhD
Pfizer
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Andrea B Apolo, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Matthew Krebs, Dr
The Christie Hospital
Shared therapeutic areas:
Daniel Castellano, MD
Hospital 12 de Octubre
Shared therapeutic areas:
Francesco Montorsi, MD
IRCCS Ospedale San Raffaele
Shared therapeutic areas:
David M Latini, PhD
Baylor College of Medicine
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Fei Ma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Ur Metser, MD
Princess Margaret Hospital, Canada
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
All 1 trials loaded